However, not only the overexpression of leptin and its receptor favors tumor progression, but also polymorphisms (variation in specific DNA sequences) of leptin or its receptor genes are considered potential mechanisms of enhanced susceptibility to develop breast cancer [136]. Here, LEP is linked to neoplasm.